Community-based exercise program effectiveness and safety for cancer survivors.
Identifieur interne : 002119 ( PubMed/Checkpoint ); précédent : 002118; suivant : 002120Community-based exercise program effectiveness and safety for cancer survivors.
Auteurs : Emily Jo Rajotte [États-Unis] ; Jean C. Yi ; K Scott Baker ; Lindsey Gregerson ; Andréa Leiserowitz ; Karen L. SyrjalaSource :
- Journal of cancer survivorship : research and practice [ 1932-2267 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Caractéristiques de l'habitat, Enquêtes et questionnaires, Exercice physique, Fatigue (rééducation et réadaptation), Femelle, Humains, Marche à pied, Mâle, Méthode en simple aveugle, Pronostic, Qualité de vie, Sujet âgé, Sujet âgé de 80 ans ou plus, Survivants, Tumeurs (), Tumeurs (rééducation et réadaptation), Évaluation de programme.
- MESH :
- rééducation et réadaptation : Fatigue, Tumeurs.
- Adulte, Adulte d'âge moyen, Caractéristiques de l'habitat, Enquêtes et questionnaires, Exercice physique, Femelle, Humains, Marche à pied, Mâle, Méthode en simple aveugle, Pronostic, Qualité de vie, Sujet âgé, Sujet âgé de 80 ans ou plus, Survivants, Tumeurs, Évaluation de programme.
English descriptors
- KwdEn :
- MESH :
- rehabilitation : Fatigue, Neoplasms.
- therapy : Neoplasms.
- Adult, Aged, Aged, 80 and over, Exercise, Female, Humans, Male, Middle Aged, Prognosis, Program Evaluation, Quality of Life, Residence Characteristics, Single-Blind Method, Surveys and Questionnaires, Survivors, Walking.
Abstract
Clinical trials have demonstrated the benefits of exercise for cancer survivors. This investigation determined the effectiveness and safety of a disseminated community-based exercise program for cancer survivors who had completed treatment.
DOI: 10.1007/s11764-011-0213-7
PubMed: 22246463
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22246463Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Community-based exercise program effectiveness and safety for cancer survivors.</title>
<author><name sortKey="Rajotte, Emily Jo" sort="Rajotte, Emily Jo" uniqKey="Rajotte E" first="Emily Jo" last="Rajotte">Emily Jo Rajotte</name>
<affiliation wicri:level="2"><nlm:affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, P.O. Box 19024, Seattle, WA 98109, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, P.O. Box 19024, Seattle, WA 98109</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yi, Jean C" sort="Yi, Jean C" uniqKey="Yi J" first="Jean C" last="Yi">Jean C. Yi</name>
</author>
<author><name sortKey="Baker, K Scott" sort="Baker, K Scott" uniqKey="Baker K" first="K Scott" last="Baker">K Scott Baker</name>
</author>
<author><name sortKey="Gregerson, Lindsey" sort="Gregerson, Lindsey" uniqKey="Gregerson L" first="Lindsey" last="Gregerson">Lindsey Gregerson</name>
</author>
<author><name sortKey="Leiserowitz, Andrea" sort="Leiserowitz, Andrea" uniqKey="Leiserowitz A" first="Andréa" last="Leiserowitz">Andréa Leiserowitz</name>
</author>
<author><name sortKey="Syrjala, Karen L" sort="Syrjala, Karen L" uniqKey="Syrjala K" first="Karen L" last="Syrjala">Karen L. Syrjala</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22246463</idno>
<idno type="pmid">22246463</idno>
<idno type="doi">10.1007/s11764-011-0213-7</idno>
<idno type="wicri:Area/PubMed/Corpus">002311</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002311</idno>
<idno type="wicri:Area/PubMed/Curation">002311</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002311</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002311</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002311</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Community-based exercise program effectiveness and safety for cancer survivors.</title>
<author><name sortKey="Rajotte, Emily Jo" sort="Rajotte, Emily Jo" uniqKey="Rajotte E" first="Emily Jo" last="Rajotte">Emily Jo Rajotte</name>
<affiliation wicri:level="2"><nlm:affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, P.O. Box 19024, Seattle, WA 98109, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, P.O. Box 19024, Seattle, WA 98109</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yi, Jean C" sort="Yi, Jean C" uniqKey="Yi J" first="Jean C" last="Yi">Jean C. Yi</name>
</author>
<author><name sortKey="Baker, K Scott" sort="Baker, K Scott" uniqKey="Baker K" first="K Scott" last="Baker">K Scott Baker</name>
</author>
<author><name sortKey="Gregerson, Lindsey" sort="Gregerson, Lindsey" uniqKey="Gregerson L" first="Lindsey" last="Gregerson">Lindsey Gregerson</name>
</author>
<author><name sortKey="Leiserowitz, Andrea" sort="Leiserowitz, Andrea" uniqKey="Leiserowitz A" first="Andréa" last="Leiserowitz">Andréa Leiserowitz</name>
</author>
<author><name sortKey="Syrjala, Karen L" sort="Syrjala, Karen L" uniqKey="Syrjala K" first="Karen L" last="Syrjala">Karen L. Syrjala</name>
</author>
</analytic>
<series><title level="j">Journal of cancer survivorship : research and practice</title>
<idno type="eISSN">1932-2267</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Exercise</term>
<term>Fatigue (rehabilitation)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasms (rehabilitation)</term>
<term>Neoplasms (therapy)</term>
<term>Prognosis</term>
<term>Program Evaluation</term>
<term>Quality of Life</term>
<term>Residence Characteristics</term>
<term>Single-Blind Method</term>
<term>Surveys and Questionnaires</term>
<term>Survivors</term>
<term>Walking</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Caractéristiques de l'habitat</term>
<term>Enquêtes et questionnaires</term>
<term>Exercice physique</term>
<term>Fatigue (rééducation et réadaptation)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Marche à pied</term>
<term>Mâle</term>
<term>Méthode en simple aveugle</term>
<term>Pronostic</term>
<term>Qualité de vie</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivants</term>
<term>Tumeurs ()</term>
<term>Tumeurs (rééducation et réadaptation)</term>
<term>Évaluation de programme</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Fatigue</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Fatigue</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Exercise</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prognosis</term>
<term>Program Evaluation</term>
<term>Quality of Life</term>
<term>Residence Characteristics</term>
<term>Single-Blind Method</term>
<term>Surveys and Questionnaires</term>
<term>Survivors</term>
<term>Walking</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Caractéristiques de l'habitat</term>
<term>Enquêtes et questionnaires</term>
<term>Exercice physique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Marche à pied</term>
<term>Mâle</term>
<term>Méthode en simple aveugle</term>
<term>Pronostic</term>
<term>Qualité de vie</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivants</term>
<term>Tumeurs</term>
<term>Évaluation de programme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Clinical trials have demonstrated the benefits of exercise for cancer survivors. This investigation determined the effectiveness and safety of a disseminated community-based exercise program for cancer survivors who had completed treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22246463</PMID>
<DateCreated><Year>2012</Year>
<Month>04</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>08</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2267</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>6</Volume>
<Issue>2</Issue>
<PubDate><Year>2012</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cancer survivorship : research and practice</Title>
<ISOAbbreviation>J Cancer Surviv</ISOAbbreviation>
</Journal>
<ArticleTitle>Community-based exercise program effectiveness and safety for cancer survivors.</ArticleTitle>
<Pagination><MedlinePgn>219-28</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11764-011-0213-7</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Clinical trials have demonstrated the benefits of exercise for cancer survivors. This investigation determined the effectiveness and safety of a disseminated community-based exercise program for cancer survivors who had completed treatment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Personal trainers from regional YMCAs received training in cancer rehabilitation and supervised twice-a-week, 12-week group exercise sessions for survivors. At baseline and post-program, validated measures assessed patient-reported outcomes (PRO) and physiologic measurements.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were collected from 221 survivors from 13 YMCA sites and 36 separate classes. All participants had data available at one time point, while matched baseline and post-program PRO and physiologic data were available for 85% (N = 187). Participants with matched data were largely female (82%), with mean age of 58 (range, 28-91 years). Time since diagnosis ranged from 1 to 48 (mean, 5.6 years), and mean time since last treatment was 3.0 (range, 1-33 years). Physiological improvements were significant in systolic (P < 0.001) and diastolic (P = 0.035) blood pressure, upper and lower body strength, the 6-min walk test (P = 0.004), and flexibility (P < 0.001). Participants reported improvements in overall health-related quality of life (P < 0.001), social support (P = 0.019), body pain (P = 0.016), fatigue (P < 0.001), insomnia (P < 0.001), and overall musculoskeletal symptoms (P = <0.001). Few injuries or lymphedema events occurred during classes.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Community-based exercise groups for cancer survivors of mixed diagnoses and ages, who have completed active treatment, have physiologic and psychosocial benefits, and are safe.</AbstractText>
<AbstractText Label="IMPLICATIONS FOR CANCER SURVIVORS" NlmCategory="CONCLUSIONS">Survivors may expect significant benefit from participating in a community-based exercise program tailored to meet their individual needs as a survivor.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rajotte</LastName>
<ForeName>Emily Jo</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo><Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D5-220, P.O. Box 19024, Seattle, WA 98109, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yi</LastName>
<ForeName>Jean C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Baker</LastName>
<ForeName>K Scott</ForeName>
<Initials>KS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gregerson</LastName>
<ForeName>Lindsey</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Leiserowitz</LastName>
<ForeName>Andréa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Syrjala</LastName>
<ForeName>Karen L</ForeName>
<Initials>KL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 CA112631</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA160684</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>01</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Cancer Surviv</MedlineTA>
<NlmUniqueID>101307557</NlmUniqueID>
<ISSNLinking>1932-2259</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2011 Feb;50(2):167-78</RefSource>
<PMID Version="1">21091401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Obesity (Silver Spring). 2012 Jun;20(6):1234-9</RefSource>
<PMID Version="1">21633403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2001 Aug 1;88(3):316-22</RefSource>
<PMID Version="1">11472719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Jun 1;112(11 Suppl):2577-92</RefSource>
<PMID Version="1">18428205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Hematol. 2011 Sep;90(9):993-1004</RefSource>
<PMID Version="1">21670973</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7</RefSource>
<PMID Version="1">12091180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Jun;5(2):167-74</RefSource>
<PMID Version="1">21225372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33</RefSource>
<PMID Version="1">21051654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 2010 Dec;91(12):1844-8</RefSource>
<PMID Version="1">21112424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Jun 20;24(18):2765-72</RefSource>
<PMID Version="1">16702582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Aug 1;24(22):3535-41</RefSource>
<PMID Version="1">16822843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 May;36(3):262-7</RefSource>
<PMID Version="1">20092952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 1998 May;7(4):301-10</RefSource>
<PMID Version="1">9610214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Nurs. 2001 Jul;10(4):528-37</RefSource>
<PMID Version="1">11822501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2011 Sep;60(3):516-26</RefSource>
<PMID Version="1">21684072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2009 Jul;41(7):1413-20</RefSource>
<PMID Version="1">19516160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Support Oncol. 2010 Jan-Feb;8(1):35-41</RefSource>
<PMID Version="1">20235422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Aug 1;24(22):3517-8</RefSource>
<PMID Version="1">16822842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Manag Res. 2010 Jun 09;2:157-64</RefSource>
<PMID Version="1">21188106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Sep 20;23(27):6587-95</RefSource>
<PMID Version="1">16170166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2000;5(5):353-60</RefSource>
<PMID Version="1">11040270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Klin Onkol. 2011;24(3):203-8</RefSource>
<PMID Version="1">21717789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2011 Jan 5;103(1):11-2</RefSource>
<PMID Version="1">21169537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2007 May;16(4):661-73</RefSource>
<PMID Version="1">17268926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource>
<PMID Version="1">19675330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 2003 Dec;26(6):1113-22</RefSource>
<PMID Version="1">14654263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Jun;127(2):447-56</RefSource>
<PMID Version="1">21424279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cardiopulm Rehabil. 1999 Jan-Feb;19(1):52-8</RefSource>
<PMID Version="1">10079421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phys Ther. 2010 Aug;90(8):1135-47</RefSource>
<PMID Version="1">20558566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Oncol Nurs. 2011 Jul;15(3):204-12</RefSource>
<PMID Version="1">21489873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Nov;124(1):163-75</RefSource>
<PMID Version="1">20734132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Support Palliat Care. 2011 Mar;5(1):1-7</RefSource>
<PMID Version="1">21192267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Heart Fail Clin. 2011 Jul;7(3):403-11</RefSource>
<PMID Version="1">21749892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2005 May 25;293(20):2479-86</RefSource>
<PMID Version="1">15914748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2012 Sep;21(9):1003-9</RefSource>
<PMID Version="1">21726015</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2006 Feb 15;106(4):751-8</RefSource>
<PMID Version="1">16400678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Care. 2003 Aug;48(8):783-5</RefSource>
<PMID Version="1">12890299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2000;9(7):847-54</RefSource>
<PMID Version="1">11297027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2011 Apr;4(4):522-9</RefSource>
<PMID Version="1">21464032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cardiopulm Rehabil. 1995 Jul-Aug;15(4):283-7</RefSource>
<PMID Version="1">8542534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2010 Sep;4(3):225-35</RefSource>
<PMID Version="1">20454867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Nurs Res. 2004 Aug;13(3):245-64</RefSource>
<PMID Version="1">15245639</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2004 Sep;36(9):1484-91</RefSource>
<PMID Version="1">15354027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2011 Sep;28(3):753-65</RefSource>
<PMID Version="1">20411366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2012 May;47(5):619-25</RefSource>
<PMID Version="1">21643022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2007 Sep;16(9):787-95</RefSource>
<PMID Version="1">17086555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Aug 20;29(24):3263-9</RefSource>
<PMID Version="1">21768465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010 Oct 26;341:c5504</RefSource>
<PMID Version="1">20978063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Aug 1;24(22):3527-34</RefSource>
<PMID Version="1">16822844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2008 Oct;9(10):993-1001</RefSource>
<PMID Version="1">19071256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Epidemiol. 2006 Mar;16(3):197-205</RefSource>
<PMID Version="1">16137893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer (Auckl). 2010 Nov 18;4:65-72</RefSource>
<PMID Version="1">21151861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2010 Jun;4(2):87-100</RefSource>
<PMID Version="1">20052559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Apr 1;97(7):1746-57</RefSource>
<PMID Version="1">12655532</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Behav Med. 2011 Feb;41(1):32-47</RefSource>
<PMID Version="1">20931309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Pract. 2002 Jul-Aug;10(4):208-15</RefSource>
<PMID Version="1">12100105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2000 Feb 1;88(3):674-84</RefSource>
<PMID Version="1">10649263</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
<QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015397" MajorTopicYN="Y">Program Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012111" MajorTopicYN="Y">Residence Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS772051</OtherID>
<OtherID Source="NLM">PMC4821160</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>10</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>12</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>1</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>1</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22246463</ArticleId>
<ArticleId IdType="doi">10.1007/s11764-011-0213-7</ArticleId>
<ArticleId IdType="pmc">PMC4821160</ArticleId>
<ArticleId IdType="mid">NIHMS772051</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Washington (État)</li>
</region>
</list>
<tree><noCountry><name sortKey="Baker, K Scott" sort="Baker, K Scott" uniqKey="Baker K" first="K Scott" last="Baker">K Scott Baker</name>
<name sortKey="Gregerson, Lindsey" sort="Gregerson, Lindsey" uniqKey="Gregerson L" first="Lindsey" last="Gregerson">Lindsey Gregerson</name>
<name sortKey="Leiserowitz, Andrea" sort="Leiserowitz, Andrea" uniqKey="Leiserowitz A" first="Andréa" last="Leiserowitz">Andréa Leiserowitz</name>
<name sortKey="Syrjala, Karen L" sort="Syrjala, Karen L" uniqKey="Syrjala K" first="Karen L" last="Syrjala">Karen L. Syrjala</name>
<name sortKey="Yi, Jean C" sort="Yi, Jean C" uniqKey="Yi J" first="Jean C" last="Yi">Jean C. Yi</name>
</noCountry>
<country name="États-Unis"><region name="Washington (État)"><name sortKey="Rajotte, Emily Jo" sort="Rajotte, Emily Jo" uniqKey="Rajotte E" first="Emily Jo" last="Rajotte">Emily Jo Rajotte</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002119 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002119 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:22246463 |texte= Community-based exercise program effectiveness and safety for cancer survivors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22246463" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |